AUSTEDO
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 23 Sept 2023)
What this means for you
Registered since 06 Feb 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86752573
- Registration number
- 5396839
- Mark type
- Design + words
- Filed
- 10 Sept 2015
- Published for opposition
- 02 Feb 2016
- Registered
- 06 Feb 2018
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of central nervous system diseases, namely, neurodegeneration, psychiatric conditions, pain, movement disorders
Owner
- AUSPEX PHARMACEUTICALS LLC, PARSIPPANY, NJ, US
- Auspex Pharmaceuticals, Inc., Parsippany, NJ, US
- Auspex Pharmaceuticals, Inc., La Jolla, CA, US
- Auspex Pharmaceuticals, Inc., La Jolla, CA, US
Prosecution history
- 11 Apr 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 23 Sept 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 23 Sept 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 23 Sept 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 Mar 2023 — TEAS SECTION 8 & 15 RECEIVED
- 06 Feb 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 14 Jul 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 14 Jul 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 14 Jul 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 06 Feb 2018 — REGISTERED-PRINCIPAL REGISTER
- 03 Jan 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Jan 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Nov 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Nov 2017 — USE AMENDMENT FILED
- 29 Nov 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL